Tender Details

Country: Sri Lanka
Summary: Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper)
LKT Ref No: 116428950
Deadline: 30 Apr 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: DHS/P/WW/341/26
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper) Bivalent Poliomyelitis Vaccine Live Oral (bOPV)10 dose vial Bivalent Poliomyelitis Vaccine Live BP,EP or USP Liquid stabilized preparation of live attenuated poliomyelitis virus of the Sabin strains type 1 and type 3. Each immunizing dose of vaccine should contain not less than 10 6 TCID50 for type 1 and 10 5.8 TCID50 for type 3 (should conform to the formulation of ratio of 10:6 for vaccine virus sero type 1 and 3 respectively). One immunizing dose should be contained preferably in two drops. i.Offers should be only from vaccine suppliers recommended by World Health Organization (WHO) for bulk purchase for the U.N. Agencies. ii.The product should be from fresh stocks and each consignment should be prepared preferably from a single batch. Each batch should accompany a certificate of analysis,lot release certificate issued by laboratory accredited by National Control Authority and Summary Protocol of vaccine production and quality control test data should be submitted for protocol review. iii.Each consignment should have a minimu m remaining shelf life of 75% at the time of r eceiving the consignment at MSD. iv.The vaccine should also comply with the general requirements for vaccines in the BP,EP or USP. v.The vaccine should meet the most recent requirements of WHO when tested by the methods outlined by WHO. vi.Cold chain monitors or WHO recommended other cold chain monitoring device should be included in each pack during delivery and the cold chain should be maintained during storage, transport and delivery of vaccines. vii.The vaccine should be protected from light and should be stored at a temperature - 20'C. 65,000 vials 35,000 vials/ August 2026 30,000 Vials/ November 2026 2 viii.Each vial should be labeled accordingly indicating both date of manufacture and expiry. ix.Must be a WHO prequalified product. x.Each vial should be provided with a suitable dropper. xi.Each vial should contain a suitable vaccine vial monitor. xii.Chief Epidemiologist should be informed two weeks prior to the arrival of vaccine
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper) - Srilanka Tender

The STATE PHARMACEUTICALS CORPORATION OF SRI LANKA, a Government sector organization in Sri Lanka, has announced a new tender for Bivalent Poliomyelitis Vaccine Live 10 dose vial (with a suitable dropper). This tender is published on SrilankaTender under LKT Ref No: 116428950 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-30.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.